Aug. 21, 2020 Price forecast | 2 weeks: -0.36% | 1 month: -1.28% | 3 months: 1.02%


USNA stock forecast

Our latest prediction for USANA Health Sciences, Inc.'s stock price was made on the Aug. 21, 2020 when the stock price was at 82.00$.

In the short term (2weeks), USNA's stock price should underperform the market by -0.36%. During that period the price should oscillate between -5.87% and +3.70%.

In the medium term (3months), USNA's stock price should outperform the market by 1.02%. During that period the price should oscillate between -15.09% and +13.82%.

Create a solid portfolio with USNA

Add USNA to your portfolio and optimize it!


About USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group. The Optimizers Nutritionals category consists of targeted supplements that support cardiovascular health, skeletal and structural health, and digestive health. The Foods Nutritionals category includes low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense-beautiful science includes premium, science-based, personal care products that support healthy skin and hair by providing topical nourishment, moisturization, and protection. The firm's brand include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

At the moment the company generates 1058M USD in revenues.

On its last earning announcement, the company reported a profit of 5.04$ per share.

The book value per share is 17.70$

USANA Health Sciences, Inc. website


Three months stock forecastAug. 21, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1058M 82.10% 159M 15.00% 110M 5.04 - - 22M 17.70 169M -20M 149M